RND3
Rho-related GTP-binding protein RhoE
Also known as: ARHE, Rho8, RhoE, RND3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61587
- Gene
- RND3
- Ensembl
- ENSG00000115963
- Chromosome
- 2
- Canonical length
- 244 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a protein which is a member of the small GTPase protein superfamily. The encoded protein binds only GTP but has no GTPase activity, and appears to act as a negative regulator of cytoskeletal organization leading to loss of adhesion. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
244 residues, UniProt reviewed canonical sequence.
>P61587|RND3
1 MKERRASQKL SSKSIMDPNQ NVKCKIVVVG DSQCGKTALL HVFAKDCFPE NYVPTVFENY
61 TASFEIDTQR IELSLWDTSG SPYYDNVRPL SYPDSDAVLI CFDISRPETL DSVLKKWKGE
121 IQEFCPNTKM LLVGCKSDLR TDVSTLVELS NHRQTPVSYD QGANMAKQIG AATYIECSAL
181 QSENSVRDIF HVATLACVNK TNKNVKRNKS QRATKRISHM PSRPELSAVA TDLRKDKAKS
241 CTVMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RND3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 146 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 146 nTPM
- liver: 123 nTPM
- urinary bladder: 101 nTPM
- breast: 93 nTPM
- smooth muscle: 58 nTPM
- gallbladder: 56 nTPM
Single-cell type
- basal keratinocytes: 1,449 nCPM
- ocular epithelial cells: 950 nCPM
- suprabasal keratinocytes: 815 nCPM
- esophageal apical cells: 796 nCPM
- endometrial secretory cells: 744 nCPM
- urothelial cells: 599 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 34 nTPM
- hypothalamus: 25 nTPM
- amygdala: 20 nTPM
- thalamus: 16 nTPM
- cerebral cortex: 14 nTPM
- hippocampal formation: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RND3.
Disease | ImmuneIEDB
Conditions an epitope on RND3 was assayed in.
- viral infectious disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.65
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- actin filament organization
- cell adhesion
- regulation of actin cytoskeleton organization
- signal transduction
- small GTPase-mediated signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Small GTPase
- Small GTPase Rho
- Small GTP-binding domain
- P-loop containing nucleoside triphosphate hydrolase
- Ras family
- Rho-related GTP-binding protein RhoE
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RND3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RND3 as an antibody target. Whether an autoantibody or antibody against RND3 could matter depends on whether native RND3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RND3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RND3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...